Aug 22 2018
Royal Philips, a global leader in health technology, today introduced the EPIQ CVx cardiovascular ultrasound system. Built on the powerful EPIQ ultrasound platform, EPIQ CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans. The initial response to the new system has been overwhelmingly positive: 95% of a group of clinicians who were shown the new EPIQ CVx believed it offered improved image quality: sharper and clearer images. Philips is also introducing the EPIQ CVxi, specifically tailored for use in the interventional lab. EPIQ CVx and EPIQ CVxi are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
“Analyzing fetal and pediatric anatomical structures requires an approach that accounts for the size and complexity of the patient,” says John Simpson, professor of pediatric and fetal cardiology at Evelina London Children’s Hospital. “I've used the EPIQ CVx cardiovascular ultrasound system as part of a pediatric or fetal assessment to help make accurate diagnoses with confidence. This includes enhanced imaging of the coronary arteries which is challenging but necessary to plan treatment, particularly in the pediatric setting."
“As pressures on healthcare systems around the world continue to increase, cardiologists have more patients to examine in less time. By using advanced 3D organ modelling, image slicing, and proven quantification, anatomical intelligence is helping make ultrasound exams easier to perform and more reproducible, ” said David Handler, Vice President and General Manager of Global Cardiology Ultrasound. “With Philips EPIQ CVx and its cardiology0centric design, clinicians can perform faster exams with enhanced diagnostic information. The EPIQ CVxi is our third-generation integrated ultrasound-angiography cath lab solution for real-time, workflow optimized image guidabce and advanced quantification for structural heart procedures.”
Designed for cardiology
EPIQ CVx will showcase in the UK at BSEcho 2018 Liverpool, stand 29, and was debuted at the British Cardiovascular Society annual conference. EPIQ CVx places cardiologists at the forefront of innovation. It includes higher processing power, exceptional image clarity and sharpness, improved exam efficiencies and more robust and reproducible quantification, enabled by anatomical intelligence. The EPIQ CVx includes TrueVue, giving clinicians the ability to see photorealistic renderings of the heart, which improves cardiac anatomy analysis by offering detailed tissue and depth perception imaging through a new virtual light source. The system provides cardiologists with high image quality through its new latest generation OLED monitor, offering a more dynamic, wider viewing angle for side-by-side image comparison. By combining the new OLED monitor with TrueVue, clinicians can make a quick, confident diagnosis.
The system offers a variety of new features including Dynamic HeartModelA.I.. Building on Philips HeartModelA.I., it uses anatomical intelligence to automatically quantify left ventricle function to produce a multi-beat analysis for adult patients. Dynamic Heart Model has been shown to reduce the amount of time to generate a 3D Ejection Fraction, an important measurement in determining how well the heart is pumping out blood, by 83%. It also delivers a high level of robustness and reproducibility, even for patients with an arrhythmia. The systems also includes the new S9-2 PureWave transducer, which simplifies pediatric cardiac exams by displaying high levels of detail and contrast resolution through the single-crystal technology. It also provides tissue information at greater depths and enhances pediatric capability for coronary artery visualization.
The EPIQ CVx includes a cardiology-specific user interface which simplifies the exam experience through a user-configurable touch-screen interface, allowing clinicians to personalize their controls and improve workflow for their cardiology exams. Philips also reaffirms its dedication to privacy and security by providing strong security capabilities and protocols.
Image Guided Therapy for structural heart repairs: combining live ultrasound and X-ray
Specifically designed for use in the cath lab, the EPIQ CVxi with EchonavigatorA.I. is Philips’ third-generation interventional solution to streamline communication between the interventional cardiologist and the echocardiographer during complex interventional exams, improving patient care and enhancing workflow. Combining live ultrasound and X-ray information into one intuitive view, EchoNavigatorA.I. helps interventional cardiologists more clearly oversee procedures along with the location of key anatomical structures. In addition, MultiVue provides more flexibility when using 3D during diagnostic or interventional procedures as the clinician can see multiple and flexible views at once.
Source: http://www.philips.com/